Skip to content Skip to navigation

Medical Services

Brightside Clinic hires medical director

March 20, 2017  |  Gary A. Enos, Editor
news
David Kushner, DO, FACP, has been named medical director at Brightside Clinic, the buprenorphine treatment organization with offices in two Illinois communities.

Report: Risk of long-term opioid use increases in initial week of treatment

March 17, 2017  |  Gary A. Enos, Editor
article
Data released this week by the Centers for Disease Control and Prevention (CDC) make a case for significant limits on initial prescriptions of opioids.

Public health researchers recommend safe injection facilities in Baltimore

March 15, 2017  |  Gary A. Enos, Editor
news
Johns Hopkins researchers suggest that two safe injection facilities (SIFs) in Baltimore would have a significant impact on reducing harms from the opioid crisis.

Study highlights threat of dual use of buprenorphine and other opioids

March 7, 2017  |  Rachael Zimlich, RN, Contributing Writer
article
Research using a pharmacy database leads to striking findings about the prevalence of other opioid use during and after buprenorphine treatment.

Readers open to idea of marijuana-inclusive treatment

February 28, 2017  |  Tom Valentino, Senior Editor
blog
Our story last week on the use of marijuana in addiction treatment has generated a lot of reader feedback, with many commenters willing to consider the practice.

Major jump in eating disorders screening projected

February 27, 2017  |  Gary A. Enos, Editor
blog
National Eating Disorders Awareness Week organizers are aiming to have 100,000 individuals participate in free online screenings during this year's campaign.

Potent carfentanil will move to China's banned list

February 20, 2017  |  Gary A. Enos, Editor
news
Chinese officials have expedited a review process to place the deadly opioid carfentanil on its controlled substances list.

Researchers quantify benefit of medication intervention in emergency care

February 14, 2017  |  Gary A. Enos, Editor
news
New research suggests that opioid-addicted individuals who receive buprenorphine during an emergency medical visit show better treatment engagement for two months following the intervention.

New Jersey opioid law mandates prescriber discussions with young patients

February 8, 2017  |  Gary A. Enos, Editor
news
Advocates believe a newly adopted New Jersey law designed to educate youths and their families about the dangers of opioid addiction could add momentum for other opioid-focused legislation.

ASAM partners on training of NPs, PAs in buprenorphine prescribing

January 17, 2017  |  Gary A. Enos, Editor
news
The American Society of Addiction Medicine (ASAM) has partnered with associations representing nurse practitioners and physician assistants to offer training courses for these professionals in buprenorphine prescribing.

Five facts about new versions of buprenorphine

January 13, 2017  |  Gary A. Enos, Editor
article
Injectable and implant versions of buprenorphine are seen as potentially significant breakthroughs in improving medication adherence and reducing diversion.

Specialty provider sees increasingly receptive audience in general medicine for addiction training

January 5, 2017  |  Gary A. Enos, Editor
article
The medical director at Caron Treatment Centers reports that today's young physicians are much more likely than their predecessors to address patients' substance use concerns head-on.

Pages

Subscribe to Medical Services